NCT00644423

Omega-3 Fatty Acids and Post Traumatic Stress Disorder (PTSD)

Omega-3 Fatty Acids and PTSD

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 18 (actual)
• Sponsor: Durham VA Medical Center · Federal
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

An increasing literature shows that omega-3 fatty acids provide numerous health benefits, including a variety of psychiatric symptoms and disorders including stress, anxiety, cognitive impairment, mood disorders (major depression and bipolar disorder) and schizophrenia. Omega-3 fatty acids may additionally represent a promising treatment strategy in patients with PTSD. Moreover, given its beneficial cardiovascular effects, adjunctive omega-3 fatty acids may also benefit the general health status of these veterans, who frequently present with a variety of comorbid medical disorders.

Detailed description

See brief summary

Conditions

• Posttraumatic Stress Disorder

Interventions

Type	Name	Description
DRUG	Omega-3 Fatty Acid	One capsule three times per day x 1 day (325mg EPA/225mg docosahexaenoic acid (DHA) tid) Two capsules three times per day x 1 day (650mg EPA/450mg DHA tid) Three capsules three times per day thereafter (975mg EPA/675mg DHA tid)
DRUG	Placebo	Matching Placebo

Timeline

• Start date: 2008-09-22
• Primary completion: 2010-07-15
• Completion: 2010-07-15
• First posted: 2008-03-26
• Last updated: 2019-08-20
• Results posted: 2019-08-20

Locations

1 site across 1 country: United States